Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Enter Clinical Collaboration to Evaluate Combination of Opdivo and Rubraca in Phase 2 and Pivotal Phase 3 Clinical Trials in Tumors Jul 31, 2017 07:00AM
Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate Combination of Opdivo (Nivolumab) and Rubraca® (Rucaparib) in Phase 2 and Pivotal Phase 3 Clinical Trials Jul 31, 2017 06:59AM
Pre-Open Stock Movers 04/13: (RPRX) (ACUR) (MDVN) Higher; (CLVS) (VRX) (S) Lower (more...) Apr 13, 2016 09:33AM
SHAREHOLDER NOTICE: Goldberg Law PC Announces An Ongoing Investigation Of Claims Against Clovis Oncology, Inc. And Encourages Shareholders To Contact The Firm Nov 17, 2015 11:12AM
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Clovis Oncology, Inc. and Encourages Shareholders to Contact the Firm Nov 16, 2015 05:29PM